CEO SUMMARY: In a transaction that was quietly negotiated, Sonic Healthcare Ltd. will purchase American Esoteric Laboratories, Inc. (AEL). News of the sale was released Friday and the sale may close in early January. Once it owns AEL, Sonic will have a major presence in Memphis, Tennessee. It will also gain regional laboratory operations in
Tag: memphis pathology lab
American Esoteric Laboratories, Inc. today announced that it has signed an extended, five-year contract to provide reference and esoteric testing services to the 14-hospital Baptist Memorial Health Care Corporation (BMHCC) in Memphis, Tennessee. This relationship was developed as part of AEL’s acquisition of Memphis Pathology Laboratories in 2004.
NEW & STEPHANELLI LAUNCH AP COMPANY
Today, Aurora Diagnostics,
CEO SUMMARY: Back in April 2004, when American Esoteric Laboratories, Inc.(AEL)launched operations, its declared ambition was to become a national esoteric testing firm. However, given the positive experiences from its acquisition of Memphis Pathology Laboratories in September 2004, AEL has evolved its core business strategy to include routine testing and to focus on regional hospital
CEO SUMMARY: Nine months after it declared that it would exit the laboratory testing business in Canada by selling its laboratories, MDS, Inc. has finally closed its first sale. Calgary Health Region, already a 50% owner of Calgary Laboratory Services, has purchased the 25% interest owned by MDS. However, the laboratory business divisions in British
On March 13, 2006, American Esoteric Laboratories, Inc. (AEL) of Brentwood, Tennessee announced the acquisition of Physicians Medical Laboratory (PML). Terms of the transaction were not disclosed. Located in Morristown, Tennessee, PML gives AEL a presence in east Tennessee. AEL has owned and operated Memphis Pathology Laboratory in west Tennessee since 2004.
VIRUS DISCOVERED IN SOME
PFIZER AND GLAXO-SK TO USE RFID TAGS IN 2005, RFID TEST IN BLOOD BANK
RADIO FREQUENCY IDENTIFICATION (RFID) is making swift progress in a variety of healthcare applications.
The Food and Drug Administration (FDA) wants to secure the nation’s drug supply through widespread use of RFID tags by 2007. To counter drug counterfeiting, some pharmaceutical companies are
CEO SUMMARY: Laboratory acquisition activity was surprisingly high during 2004. One reason is that new buyers appeared in the marketplace. However, all buyers have specific acquisition criteria. When a selling lab meets that criteria, it can expect multiple bidders and a strong purchase price. Here’s a review of 2004’s lab acquisition activity, with commentary about
CEO SUMMARY: Even as the best of its lab testing joint ventures with hospitals and health systems prove profitable, MDS Diagnostic Services is taking active steps to resolve its participation as a partner. In a candid interview, its President and CEO acknowledged the best attributes of such joint ventures and identified specific business dynamics which
CEO SUMMARY: Memphis Pathology Labs’ two hospital owners and their JV partner, MDS, surprised many with the sale of the lab venture to American Esoteric Laboratories (AEL). It’s the end of a successful joint venture between several hospitals and a commercial laboratory company. It also positions AEL to use Memphis as a base to market
CEO SUMMARY: It’s the final chapter of the “Canadian Invasion” of the U.S. laboratory testing market. In the mid-1990s, both MDS and Dynacare built a sizeable presence in the United States as they both worked to develop joint ventures with hospital laboratories. Dynacare was acquired by LabCorp in 2002. In selling two U.S. lab operations,